Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

Category Primary study
JournalBlood
Year 2019
This article has no abstract
Epistemonikos ID: f7914fc95090b57014884f7ae5f9e120a7e24822
First added on: Feb 13, 2025